Trandolapril And Verapamil Hydrochloride recalls
Trandolapril And Verapamil Hydrochloride products have been recalled 1 time, most recently on 30 Aug 2023. The recalling company is usually Glenmark Pharmaceuticals Inc., USA. The most common reason is potency & assay.
Total recalls1since 2023
Last 12 months0reported
Class I00% of total
Ongoing1latest 30 Aug 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 1 100%
Why trandolapril and verapamil hydrochloride is recalled
Companies
Product types
By year
Ongoing trandolapril and verapamil hydrochloride recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Trandolapril and Verapamil Hydrochloride Extended-Release recalledTrandolapril And Verapamil Hydrochloride | Glenmark Pharmaceuticals Inc., USA | Potency & Assay | Nationwide |
All trandolapril and verapamil hydrochloride recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Trandolapril and Verapamil Hydrochloride Extended-Release recalledTrandolapril And Verapamil Hydrochloride | Glenmark Pharmaceuticals Inc., USA | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.